ArticleFrontiers in immunology2022

Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants.

Justin Mark Lunderberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.